Showing results (31-40 of 380) with videos related to

Sort By:
Pageof 38
Ebiomedicine|April 19, 2022
Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapyHonggang Ying, Jian Xu, Xiaozhen Zhang, et al.
Cancer Letters|October 24, 2025
Cancer dormancy and metabolism: From molecular insights to translational opportunitiesYashi Wang, Lingyue Liu, Xiaozhen Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 25, 2025
Reciprocal regulation of MMP-28 and EGFR is required for sustaining proliferative signaling in PDACZhengtao Hong, Xing Huang, Linghao Xia, et al.
Hepatology Communications|January 8, 2025
Biological and clinical role of TREM2 in liver diseasesKe Ma, Shouliang Guo, Jin Li, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|February 14, 2022
One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatmentXing Huang, Gang Zhang, Tianyu Tang, et al.
Molecular Medicine (Cambridge, Mass.)|June 18, 2022
RCAN1-mediated calcineurin inhibition as a target for cancer therapyMengyi Lao, Xiaozhen Zhang, Hanshen Yang, et al.
Oncotargets and Therapy|July 17, 2019
Stereotactic body radiotherapy as the initial treatment for hepatocellular carcinoma with extensive inferior vena cava and atrium tumor thrombusYongjie Shui, Xiaoping Zhu, Jianjun Wu, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|November 22, 2023
Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunitySirui Zhang, Xiaozhen Zhang, Hanshen Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 26, 2023
The "Self-eating" of cancer-associated fibroblast: A potential target for cancerYan Chen, Xiaozhen Zhang, Hanshen Yang, et al.
Signal Transduction and Targeted Therapy|September 19, 2023
mRNA vaccines in disease prevention and treatmentGang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Pageof 38